Purixan Suspension
Product Images NDC 62484-0020

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Purixan (NDC 62484-0020). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nova Laboratories, Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Figure1)

Chemical structure diagram showing the molecular structure of the active ingredient in PURIXAN 20 mg/mL oral suspension by Nova Laboratories, Ltd. The structure includes sulfur and nitrogen atoms within a heterocyclic ring.*

FDA Label Image

Purixan Bottle Label (Bottle Label)

The image shows a label for PURIXAN oral suspension with a strength of 20 mg/mL (2000 mg/100 mL). It is a human prescription drug provided by Nova Laboratories, Ltd. The label includes product name, concentration, instructions to shake before use, storage conditions, and a barcode. The label also indicates a 100 mL bottle size and includes inactive ingredient details and dosing information warnings.*

FDA Label Image

Purixan Carton Label (Carton Label)

Label for PURIXAN (mercaptopurine) oral suspension 20 mg/mL, 100 mL bottle. The label includes active ingredient strength (2000 mg/100 mL), storage instructions, manufacturer Nova Laboratories Ltd, and distributor Rare Disease Therapeutics, Inc. Directions to shake vigorously before use and warnings to keep out of reach of children are present. Barcode and lot information panels are also visible.*

FDA Label Image

Figure A (Nova 04)

An illustration showing a hand holding a small bottle with a child-resistant cap, shaking it in an up-and-down motion. Arrows indicate the direction of shaking to mix the liquid suspension inside the bottle.*

FDA Label Image

Figure B (Nova 05)

An instructional illustration showing one hand pressing down on the cap of a container while the other hand holds the container steady, indicating how to open or close it with a push-and-turn motion.*

FDA Label Image

Figure C (Nova 06)

An instructional illustration showing two hands opening a bottle. One hand grips the bottle while the other hand is pressing down on and turning the cap, guided by a downward arrow indicating the direction to open.*

FDA Label Image

Figure E (Nova 07)

Illustration showing a hand holding an oral suspension bottle with a syringe inserted into the bottle to draw liquid, indicated by a downward arrow above the syringe. No label text is visible.*

FDA Label Image

Figure F (Nova 08)

An instructional illustration showing two hands preparing an oral suspension medication. One hand holds a bottle inverted downward, while the other hand grips a mixing or dosing device, with an arrow indicating the direction of movement to extract or prepare the dose.*

FDA Label Image

Figure D (Nova 09)

An instructional illustration showing a hand holding a syringe. The syringe parts labeled include the plunger, barrel, and tip. The image highlights the syringe's markings on the barrel for measurement.*

FDA Label Image

Purixan Serialized Carton Example

PURIXAN (mercaptopurine) oral suspension 20 mg/mL strength is shown with the concentration express as 2000 mg/100 mL. The label includes the product name, generic name, dosage form, NDC 62484-0020-2, lot number, expiration date, and a QR code. The product is from Nova Laboratories, Ltd.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.